Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wolz

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Plos One|January 4, 2013
Structural MRI in frontotemporal dementia: comparisons between hippocampal volumetry, tensor-based morphometry and voxel-based morphometryMiguel Ángel Muñoz-Ruiz, Päivi Hartikainen, Juha Koikkalainen, et al.
European Stroke Journal|April 2, 2020
Imaging markers associated with the development of post-stroke depression and apathy: Results of the Cognition and Affect after Stroke - a Prospective Evaluation of Risks studyElles Douven, Julie Staals, Whitney M Freeze, et al.
Current Alzheimer Research|December 20, 2014
Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State IndexAnette Hall, Jussi Mattila, Juha Koikkalainen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 28, 2026
Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease but without amyloid deposits on positron emission tomography: Results from Bio-Hermes Study participantsRichard C Mohs, Douglas W Beauregard, Lynne Hughes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2025
Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challengesAriane Bollack, Mahnaz Shekari, Lyduine E Collij, et al.
EJNMMI Research|May 13, 2022
Impact of cerebral blood flow and amyloid load on SUVR biasFiona Heeman, Maqsood Yaqub, Janine Hendriks, et al.
Neurology|March 1, 2013
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCIStephanie J B Vos, Ineke A van Rossum, Frans Verhey, et al.
Neurobiology of Aging|January 24, 2012
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCIStephanie Vos, Ineke van Rossum, Leah Burns, et al.
Neurology|September 29, 2012
Injury markers predict time to dementia in subjects with MCI and amyloid pathologyIneke A van Rossum, Stephanie J B Vos, Leah Burns, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2024
Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management StudyLyduine E Collij, Gérard N Bischof, Daniele Altomare, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Plos One|January 4, 2013
Structural MRI in frontotemporal dementia: comparisons between hippocampal volumetry, tensor-based morphometry and voxel-based morphometryMiguel Ángel Muñoz-Ruiz, Päivi Hartikainen, Juha Koikkalainen, et al.
European Stroke Journal|April 2, 2020
Imaging markers associated with the development of post-stroke depression and apathy: Results of the Cognition and Affect after Stroke - a Prospective Evaluation of Risks studyElles Douven, Julie Staals, Whitney M Freeze, et al.
Current Alzheimer Research|December 20, 2014
Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State IndexAnette Hall, Jussi Mattila, Juha Koikkalainen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 28, 2026
Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease but without amyloid deposits on positron emission tomography: Results from Bio-Hermes Study participantsRichard C Mohs, Douglas W Beauregard, Lynne Hughes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2025
Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challengesAriane Bollack, Mahnaz Shekari, Lyduine E Collij, et al.
EJNMMI Research|May 13, 2022
Impact of cerebral blood flow and amyloid load on SUVR biasFiona Heeman, Maqsood Yaqub, Janine Hendriks, et al.
Neurology|March 1, 2013
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCIStephanie J B Vos, Ineke A van Rossum, Frans Verhey, et al.
Neurobiology of Aging|January 24, 2012
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCIStephanie Vos, Ineke van Rossum, Leah Burns, et al.
Neurology|September 29, 2012
Injury markers predict time to dementia in subjects with MCI and amyloid pathologyIneke A van Rossum, Stephanie J B Vos, Leah Burns, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2024
Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management StudyLyduine E Collij, Gérard N Bischof, Daniele Altomare, et al.
Pageof 6